133 related articles for article (PubMed ID: 3905721)
1. Immunohistochemical staining of macrophages in the skin lesions of leprosy: the role of antibody to mycobacteria in human serum and various polyclonal immune rabbit antisera.
Kahn HJ; Thorner P; Baumal R; Yeger H; Bailey D; Marks A; From L; Fisher BK; Lynde C
Histochem J; 1985 Sep; 17(9):1009-20. PubMed ID: 3905721
[TBL] [Abstract][Full Text] [Related]
2. Association of the mycobacterial 30-kDa region proteins with the cutaneous infiltrates of leprosy lesions. Evidence for the involvement of the major mycobacterial secreted proteins in the local immune response of leprosy.
Rambukkana A; Das PK; Krieg S; Faber WR
Scand J Immunol; 1992 Jul; 36(1):35-48. PubMed ID: 1615282
[TBL] [Abstract][Full Text] [Related]
3. High antibody levels to the mycobacterial fibronectin-binding antigen of 30-31 kD in tuberculosis and lepromatous leprosy.
Espitia C; Sciutto E; Bottasso O; González-Amaro R; Hernández-Pando R; Mancilla R
Clin Exp Immunol; 1992 Mar; 87(3):362-7. PubMed ID: 1371953
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the antigenic profile of Mycobacterium leprae: cross-reactive and unique specificities of human and rabbit antibodies.
Ehrenberg JP; Gebre N
Scand J Immunol; 1987 Dec; 26(6):673-81. PubMed ID: 3321410
[TBL] [Abstract][Full Text] [Related]
5. Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labeling of ultrathin sections.
Rastogi N; Cadou S; Hellio R
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):278-91. PubMed ID: 2071985
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV
Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852
[TBL] [Abstract][Full Text] [Related]
7. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
8. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U
Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752
[TBL] [Abstract][Full Text] [Related]
9. Antibody response in rabbits to immunization with Mycobacterium leprae.
Harboe M; Closs O; Bjorvatn B; Kronvall G; Axelsen NH
Infect Immun; 1977 Dec; 18(3):792-805. PubMed ID: 338491
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of the M4 macrophage population in leprosy skin lesions.
de Sousa JR; Lucena Neto FD; Sotto MN; Quaresma JAS
BMC Infect Dis; 2018 Nov; 18(1):576. PubMed ID: 30442123
[TBL] [Abstract][Full Text] [Related]
11. Comparison of S-100 and OKT6 antisera in human skin.
Modlin RL; Rowden G; Taylor CR; Rea TH
J Invest Dermatol; 1984 Sep; 83(3):206-9. PubMed ID: 6381607
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterial antigens in antibody responses of leprosy patients.
Kronvall G; Bjune G; Stanford J; Menzel S; Samuel D
Int J Lepr Other Mycobact Dis; 1975; 43(4):306. PubMed ID: 58844
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
14. Similarity between mycobacterial and human epidermal antigens.
van den Akker TW; Naafs B; Kolk AH; De Glopper-van der Veer E; Chin RA; Lien A; Van Joost T
Br J Dermatol; 1992 Oct; 127(4):352-8. PubMed ID: 1384646
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of Migration Inhibitory Factor (MIF) and
Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
Front Immunol; 2018; 9():246. PubMed ID: 29487601
[TBL] [Abstract][Full Text] [Related]
16. Evidence that coating of Mycobacterium leprae surface antigens reduces its ability to hinder host microbicidal functions.
Rastogi N; Frehel C
Zentralbl Bakteriol; 1990 Mar; 272(3):337-46. PubMed ID: 2184820
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 22 species of Mycobacteria by immunodiffusion against an absorbed reference leprosy serum.
Gillis TP; Abe M; Bullock WE; Rojas-Espinosa O; Garcia-Ortigoza E; Draper P; Kirchheimer W; Buchanan TM
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):287-93. PubMed ID: 6172393
[TBL] [Abstract][Full Text] [Related]
18. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
Brett SJ; Draper P; Payne SN; Rees RJ
Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
20. An electron microscopic study on macrophages and lymphocytes in lepromatous and borderline leprosy.
Burchard GD; Bierther M
Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):64-9. PubMed ID: 3889192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
